MONTREAL, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or “ATW Tech”) (TSX-V: ATW), is proud to...
2021-best-in-klas-universal-viewer-imaging Philips Image Viewer Vue Motion for Clinicìans Philips Vue Motion for Radiologists Philips Vue PACS for 3 screen view...
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment...
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
STAR candidates for the treatment of Gaucher Disease enhance GCase activity in a neuronal cell model and reduce toxic accumulation...
– Company outlining large global rare cholestatic liver disease opportunity – – Advancing plans for anticipated odevixibat U.S. and EU...
Targeting a pre-NDA meeting with FDA in Q2 2021NEWTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:...
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) will release its results for the fourth...
WARSAW, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on...
Record Q1 Sales, With Nearly 3,600% Year-Over-Year QAPs GrowthMISSISSAUGA, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:...
Topline results from open-label safety study (NORSE THREE) on target for Q2 2021MONMOUTH JUNCTION, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE)...
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the expiration date results of...
Shared Commitment to Change, New Prescriber Realities, Model Evolution and Engagement Transformation Expected to be Critical DriversMORRISVILLE, N.C., Feb. 11,...
BURLINGTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
EMERYVILLE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, today...
Net cash used in operating and investing activities was $19.1 million in the fourth quarter and $80.6 million for the...
BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its...
First in New Jersey to standardize on needle-free blood collection procedure, Holy Name builds on its reputation as a technology...
Brings Track Record of Success to Expanded RoleRALEIGH, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI),...
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy...